Guest Editorial: Warning Letters ? A Symptom?

Publication
Article
BioPharm InternationalBioPharm International-03-15-2002
Volume 15
Issue 3

by Steven S. Kuwahara, Titan Pharmaceuticals Numerous warning letters and consent decrees have revealed problems in coping with even simple parts of the GMPs.

Recent Videos
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Related Content
© 2025 MJH Life Sciences

All rights reserved.